Michelle Dawson posts

Post published on Twitter/X on 12 Feb 2013 23:06

Back to posts Previous post Next post
Twitter/X Clinical trial clinicaltrials.gov External link integrated into the post Autism terms
Open original post

Information about the link integrated into the post

Clinical trial

Holland Bloorview Kids Rehabilitation Hospital, McMaster University, Unity Health Toronto (2014). INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders. ClinicalTrials.gov. Holland Bloorview Kids Rehabilitation Hospital.

More information

Structured cited links

1 cited resource

Clinical trial Fetched Post clinicaltrials.gov

Holland Bloorview Kids Rehabilitation Hospital, McMaster University, Unity Health Toronto (2014). INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders. ClinicalTrials.gov. Holland Bloorview Kids Rehabilitation Hospital.

Publication date
2014
Identifier
NCT01788072
Authors
Holland Bloorview Kids Rehabilitation Hospital, McMaster University, Unity Health Toronto
Source
ClinicalTrials.gov
Reference type
clinical_trial
Publisher
Holland Bloorview Kids Rehabilitation Hospital
Metadata source
clinicaltrials.gov

Abstract

There is substantial evidence from animal model and healthy control data, that oxytocin is involved in the modulation of social cognition. In addition, recent genetics and plasma level studies suggest a possible role for oxytocin in the pathophysiology of Autism Spectrum Disorders (ASD). As a large number of children with ASD are transitioning into adulthood and will likely require treatment, the lack of data to make meaningful treatment recommendations to facilitate adult living is an urgent issue. This study will examine the effect of intranasal oxytocin (IN-OXT) on social function in adults with ASD. It is hypothesized that IN-OXT will be superior to placebo in improving social function by the end of study treatment.

Open source